Chembio Diagnostic Systems, Inc.
Chembio develops, manufactures, licenses, and markets POC diagnostics and technology for the detection of infectious and other diseases. Chembio is now marketing and selling SURE CHECK® HIV 1/2 Assay which previously was marketed in the US as Clearview® Complete. Our Next Generation DPP® technology is ideal for multiplexing antigen and/or antibody detection. Chembio also offers DPP® HIV 1/2 and HIV 1/2 STAT-PAK® assays. Ex-US, Chembio markets DPP® HIV-Syphilis, STAT-VIEW® HIV 1/2 and STAT-PAK.
Included in the Export Interest Directory? Yes
Products to be exported: DPP HIV-SYPHILS ASSAY, STAT-VIEW HIV 1/2 ASSAY, HIV 1/2 STAT-PAK ASSAY, DPP SYPHILS SCREEN & CONFIRM ASSAY, CHAGAS STAT-PAK ASSAY, DPP ZIKA IgM/IgG SYSTEM
Countries of Interest: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Egypt, Ethiopia, Finland, France, France, Metropolitan, Germany, Ghana, Greece, Greenland, Grenada, Guam, Guatemala, Guinea, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Korea (South), Kuwait, Laos, Lebanon, Liberia, Lithuania, Macedonia, Malaysia, Mexico, Micronesia, Monaco, Mozambique, Namibia, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Russian Federation, Rwanda, Saint Lucia, Saint Vincent and The Grenadines, Samoa, Saudi Arabia, Serbia, Singapore, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Trinidad and Tobago, Turks and Caicos Islands, Uganda, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe